The Broad Institute, based in Cambridge, MA, is a leading multidisciplinary research community dedicated to improving human health. It has processed over 1.1 million COVID-19 tests, accounting for one in every 20 tests in the U.S., demonstrating significant public health impact. The institute also pioneers innovative tools like a cell annotation service for single-cell RNA sequencing, underscoring its role in advancing biomedical research and technology.

‌